Pfizer Prepares to Divest Final Share of Haleon as Strategic Shift Takes Shape

Pfizer Inc. is making significant moves as it aims to fully divest its stake in Haleon, the consumer healthcare business it previously shared with GlaxoSmithKline (GSK). The pharmaceutical giant has announced plans to execute a final sale of its shareholding in Haleon, a move that signifies a strategic shift as Pfizer refocuses on enhancing its core pharmaceutical and vaccine operations.

Continue reading